226 related articles for article (PubMed ID: 37252797)
21. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.
Rickels R; Herz HM; Sze CC; Cao K; Morgan MA; Collings CK; Gause M; Takahashi YH; Wang L; Rendleman EJ; Marshall SA; Krueger A; Bartom ET; Piunti A; Smith ER; Abshiru NA; Kelleher NL; Dorsett D; Shilatifard A
Nat Genet; 2017 Nov; 49(11):1647-1653. PubMed ID: 28967912
[TBL] [Abstract][Full Text] [Related]
22. The cancer COMPASS: navigating the functions of MLL complexes in cancer.
Ford DJ; Dingwall AK
Cancer Genet; 2015 May; 208(5):178-91. PubMed ID: 25794446
[TBL] [Abstract][Full Text] [Related]
23. Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.
Lee J; Saha PK; Yang QH; Lee S; Park JY; Suh Y; Lee SK; Chan L; Roeder RG; Lee JW
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19229-34. PubMed ID: 19047629
[TBL] [Abstract][Full Text] [Related]
24. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract][Full Text] [Related]
25. MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.
Lai B; Lee JE; Jang Y; Wang L; Peng W; Ge K
Nucleic Acids Res; 2017 Jun; 45(11):6388-6403. PubMed ID: 28398509
[TBL] [Abstract][Full Text] [Related]
26. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
27. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.
Lee S; Lee J; Lee SK; Lee JW
Mol Endocrinol; 2008 Jun; 22(6):1312-9. PubMed ID: 18372346
[TBL] [Abstract][Full Text] [Related]
28. MLL3 regulates the
Zhu C; Soto-Feliciano YM; Morris JP; Huang CH; Koche RP; Ho YJ; Banito A; Chen CW; Shroff A; Tian S; Livshits G; Chen CC; Fennell M; Armstrong SA; Allis CD; Tschaharganeh DF; Lowe SW
Elife; 2023 Jun; 12():. PubMed ID: 37261974
[TBL] [Abstract][Full Text] [Related]
29. The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program.
Wang X; Rosikiewicz W; Sedkov Y; Mondal B; Martinez T; Kallappagoudar S; Tvardovskiy A; Bajpai R; Xu B; Pruett-Miller SM; Schneider R; Herz HM
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35820704
[TBL] [Abstract][Full Text] [Related]
30. MLL3/MLL4 enzymatic activity shapes DNA replication timing.
Gökbuget D; Boileau RM; Lenshoek K; Blelloch R
bioRxiv; 2023 Dec; ():. PubMed ID: 38106216
[TBL] [Abstract][Full Text] [Related]
31. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.
Yan J; Chen SA; Local A; Liu T; Qiu Y; Dorighi KM; Preissl S; Rivera CM; Wang C; Ye Z; Ge K; Hu M; Wysocka J; Ren B
Cell Res; 2018 Feb; 28(2):204-220. PubMed ID: 29313530
[TBL] [Abstract][Full Text] [Related]
32. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.
Wang P; Lin C; Smith ER; Guo H; Sanderson BW; Wu M; Gogol M; Alexander T; Seidel C; Wiedemann LM; Ge K; Krumlauf R; Shilatifard A
Mol Cell Biol; 2009 Nov; 29(22):6074-85. PubMed ID: 19703992
[TBL] [Abstract][Full Text] [Related]
33. Conservation of epigenetic regulation by the MLL3/4 tumour suppressor in planarian pluripotent stem cells.
Mihaylova Y; Abnave P; Kao D; Hughes S; Lai A; Jaber-Hijazi F; Kosaka N; Aboobaker AA
Nat Commun; 2018 Sep; 9(1):3633. PubMed ID: 30194301
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
[TBL] [Abstract][Full Text] [Related]
35. ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.
Kim DH; Lee J; Lee B; Lee JW
Mol Endocrinol; 2009 Oct; 23(10):1556-62. PubMed ID: 19556342
[TBL] [Abstract][Full Text] [Related]
36. Circadian clock function does not require the histone methyltransferase MLL3.
Baxter M; Poolman T; Cunningham P; Hunter L; Voronkov M; Kitchen GB; Goosey L; Begley N; Kay D; Hespe A; Maidstone R; Loudon ASI; Ray DW
FASEB J; 2022 Jul; 36(7):e22356. PubMed ID: 35704036
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic balance of gene expression by Polycomb and COMPASS families.
Piunti A; Shilatifard A
Science; 2016 Jun; 352(6290):aad9780. PubMed ID: 27257261
[TBL] [Abstract][Full Text] [Related]
38. Mutational and expressional analysis of MLL genes in gastric and colorectal cancers with microsatellite instability.
Je EM; Lee SH; Yoo NJ; Lee SH
Neoplasma; 2013; 60(2):188-95. PubMed ID: 23259788
[TBL] [Abstract][Full Text] [Related]
39. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract][Full Text] [Related]
40. H3K4 Methyltransferase Activity Is Required for MLL4 Protein Stability.
Jang Y; Wang C; Zhuang L; Liu C; Ge K
J Mol Biol; 2017 Jun; 429(13):2046-2054. PubMed ID: 28013028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
